home   genetic news   bioinformatics   biotechnology   literature   journals   ethics   positions   events   sitemap
  HUM-MOLGEN -> Genetic News | search  

Risk Factor for Common Kidney Disease

  September, 18 2008 8:27
your information resource in human molecular genetics

Scientists have identified the first common genetic variants that increase risk of end-stage kidney disease (ESKD), report two studies published online this week in Nature Genetics. ESKD is characterized by the near-total loss of kidney function, which requires dialysis or a transplant, and affects millions of people worldwide every year.

In the American population ESKD is more common in African Americans than in European Americans. This difference can be exploited by a method known as 'admixture mapping', in which the genome is scanned for variants that occur both more frequently in individuals with the disease and in regions that are inherited from African populations.

Two groups led by Wen Hong Linda Kao and Cheryl Winkler used this approach to show that variants in the gene MYH9 are associated with susceptibility to ESKD and a specific form of ESKD, known as focal segmental glomerulosclerosis (FSGS), respectively. MYH9, which is expressed in the kidney, encodes one of a family of proteins that make up nonmuscle myosin, and has diverse roles in cells. The authors suggest that variation at MYH9 accounts for a substantial fraction of the increased risk of ESKD in African Americans.

Author contacts:

Cheryl Winkler (National Cancer Institute, Frederick, MD, USA)
E-mail: winkler@ncifcrf.gov

Wen Hong Linda Kao (Johns Hopkins University, Baltimore, MD, USA)
E-mail: wkao@jhsph.edu

Abstracts available online:
Paper 1.
Paper 2.

(C) Nature Genetics press release.

Message posted by: Trevor M. D'Souza

print this article mail this article
Latest News
Variants Associated with Pediatric Allergic Disorder

Mutations in PHF6 Found in T-Cell Leukemia

Genetic Risk Variant for Urinary Bladder Cancer

Antibody Has Therapeutic Effect on Mice with ALS

Regulating P53 Activity in Cancer Cells

Anti-RNA Therapy Counters Breast Cancer Spread

Mitochondrial DNA Diversity

The Power of RNA Sequencing

‘Pro-Ageing' Therapy for Cancer?

Niche Genetics Influence Leukaemia

Molecular Biology: Clinical Promise for RNA Interference

Chemoprevention Cocktail for Colon Cancer

more news ...

Generated by News Editor 2.0 by Kai Garlipp
WWW: Kai Garlipp, Frank S. Zollmann.
7.0 © 1995-2023 HUM-MOLGEN. All rights reserved. Liability, Copyright and Imprint.